Orphan Drug Inrebic Approved by the FDA

Orphan Drugs

Orphan drugs treat diseases that are so rare they are not profitable to produce without government assistance. They are intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that:

Examples of orphan drugs include...

Tokio Marine HCC – Stop Loss Group (TMHCC) is committed to keeping you informed and up-to-date on industry news and changes that affect your clients' self-funding needs. TMHCC is a leading provider of medical stop loss insurance provided through brokers, consultants and third-party administrators. By listening to the demands of the market, we have developed exceptional products, unparalleled resources and value-added services that set us apart in the industry.

Visit our website to learn more about our innovative stop loss, Taft-Hartley, captive and organ transplant solutions.

*Data from Stacy Borans, MD, Founder and Chief Medical Officer of Advanced Medical Strategies (AMS)